Improved outcomes in patients with chronic lymphocytic leukaemia infected during the omicron BA.5 subvariant surge
Description
Patients with chronic lymphocytic leukaemia (CLL) infected with SARS-CoV-2 are at increased risk of severe COVID-19 and death. The outcomes of CLL patients with COVID-19 during the omicron subvariants and in particular with BA.5 are not fully
